Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet to deliver automation to the Baltics’ first biogas plant fired with household and commercial biowaste

Valmet Oyj’s trade press release on January 19, 2022 at 1:00 p.m. EETValmet will deliver automation to the Baltics’ first biogas plant fired with household and commercial biowaste. Built by BioWOIMA Finland Oy in Tallinn, Estonia, it will produce biomethane for the natural gas network and fuel for compressed natural gas-powered vehicles. Biofertilizer for land improvement is also produced as a by-product. The order is included in Valmet’s orders received of the fourth quarter 2021. The delivery will take place in May 2022, and the new biogas plant will be ready for operation in 2023. “

World Water Week 2022 opens for sessions and seminar proposals

World Water Week 2022 will take place online and in Stockholm and the application process for hosting a session and seminar is now open.World Water Week is where academia meets decision-makers and where experience meets young perspectives, to make the world a more water-wise place. It is where knowledge is shared, and solutions take shape. Applications are open to organizations from all sectors, striving to advance knowledge in a water-related field. To those who want to share innovative findings, tools or processes that influence the ways we manage and use water? Deadline for all

Cloud-based software solutions to support healthcare delivery

With the acquisition of Talis Clinical LLC, global medtech supplier Getinge expands its connectivity solutions with a vendor agnostic interoperable offering focused on high acuity care areas where advanced clinical and operational guidance can support the delivery of improved clinical outcomes and resource management. The Talis Clinical solutions, acquired by Getinge in late 2021, are designed to connect to medical devices, integrate with patient data, provide meaningful insights and deliver those insights to the right decision makers in a timely fashion. The tools support and

SBB controls 97.5 percent of the shares in Amasten and extends the acceptance period for the mandatory offer

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further registration documents, filings or other measures in addition to those required under Swedish law. On 20 December 2021, Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) announced a mandatory public offer to

Career story: “If you’re interested in health tech, this is probably the best workplace in the industry”

To celebrate Planmeca’s 50th anniversary, we are releasing a series of career stories from our incredible employees. These stories introduce some of the experts behind our pioneering dental innovations and show a glimpse behind the scenes at Planmeca headquarters in Helsinki. In our last article of the series, Product Development Director Sakari Kettunen describes his road from an eager MSc student in the mid-00s to the top of Planmeca’s imaging software development in 2022. Who: Sakari Kettunen, M.Sc. (Tech.), Automation TechnologyProduct Development Director, Software, X-

Approval of COVID19-study

Maastricht University Hospital receives approvals to start study with Annexin Pharmaceuticals drug candidate, ANXV, in patients with COVID19.STOCKHOLM, SWEDEN (January 19, 2022) – Annexin Pharmaceuticals AB (publ) announces that its collaborators at Maastricht University Hospital, Maastricht, The Netherlands, have received approvals from the Dutch regulatory authority and Hospital committees to start a trial with ANXV (a recombinant human Annexin A5) in hospitalised COVID-19 patients. The study follows upon Annexin Pharmaceutical’s completed Phase 1 trial of ANXV in healthy volunteers.

BioStock: Xintela advances to clinical phase in OA and difficult-to-heal wounds in 2022

There has been no shortage of news in 2021 for Xintela. With positive study results in several indications, as well as a newly recruited CEO to lead the subsidiary Targinta, Xintela is looking ahead to 2022 as they are expected enter clinical phase with two of their development projects. BioStock contacted Xintela’s CEO Evy Lundgren-Åkerlund to find out more about the progress in 2021 and the plans for 2022.Read the full article at biostock.se: https://www.biostock.se/en/2022/01/xintela-advances-to-clinical-phase-in-oa-and-difficult-to-heal-wounds-in-2022/ This is a press release from

Coloreel closes new deal with ZSK Machines in the US

Coloreel, with its unique technology for digital dyeing of textile thread on-demand for more sustainable and creative embroideries, expand their business with the sale of four units with an additional new US distribution partner ZSK Machines, a division of Notcina Corporation.Sven Öquist, VP Sales at Coloreel Group AB comments: “This is a natural next step in our partnership with ZSK and enable us additional possibility to grow our business in the US. ZSK Machines has great reach into the US embroidery market and provides excellent customer solutions and support. I am looking forward to

Howwe Technologies presents an expanded management team

The management team at Howwe Technologies is expanded with two members; Jacob Burenstam, Chief Product Officer (CPO), and Katarina Bennich, Chief Marketing Officer (CMO). At the same time, recruitment to the company's sales team has been made to further support the company's growth journey.- We have a strong growth period ahead of us, locally and globally, with the US in focus. The expansion of the management team with two central positions within the company, together with other new recruitments, are strategically important steps for us on our journey. We look forward to taking new steps

Invitation to conference call Year-End Report January 1 – December 31, 2021

Byggmax year-end report for 2021 will be published on Wednesday January 26, at approximately 08.00 AM. A teleconference will be held on the same day, in English, at 10.30 AM.Byggmax CEO Mattias Ankarberg and CFO Helena Nathhorst will present the results for 2021 and answer questions. The presentation material will be available from 08,30 AM on January 26, at www.byggmax.se under Financial Information / Financial reports.To join the conference call the following numbers:SE: +46 856642651 PIN: 80425280#UK: +44 3333000804 PIN: 80425280#For other countries see the separate file

FCG partners with IK to build a leading GRC services provider in the European market

FCG Group AB (“FCG”) is pleased to announce a partnership with IK Partners (“IK”), with the target to become a leading governance, risk management and compliance (“GRC”) services provider in the European market. IK acquires its stake in FCG from Bridgepoint Group plc (“Bridgepoint”), becoming the new majority owner.IK, a European private equity firm, announced today that IK Small Cap III Fund has signed an agreement to acquire FCG, from international private equity group Bridgepoint. The deal, which is subject to customary regulatory approvals, is expected to close in the second quarter of

Management change in Thunderful Group

Thunderful Group AB’s (“Thunderful”) CFO Anders Maiqvist has decided to leave his current position as CFO of Thunderful. Maiqvist will remain as CFO until the process of recruiting a successor is completed and will subsequently move into a new role supporting Thunderful in gaming M&A on a consulting basis.Anders Maiqvist joined Bergsala as Chief Financial Officer in 2016. He has since been involved in consolidating the group of companies co-owned by Bergsala into Thunderful Group in 2019, where he took on the role as CFO, as well as with the subsequent IPO in December 2020. Going forward,

Persistent T cell response to omicron after infection and vaccination

The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognise omicron, scientists at Karolinska Institutet in Sweden report in a study published in the journal Nature Medicine.Omicron has rapidly become the dominant variant of the SARS-CoV-2 virus. New data indicate that omicron is not only more infectious than previous variants, it can also infect people with previous immunity by evading what are known as neutralising antibodies. Serious disease seems, however, to be relatively

BAWAT INTENDS TO LIST ITS SHARES ON NASDAQ FIRST NORTH PREMIER GROWTH MARKET STOCKHOLM

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Stockholm, Sweden, January 19, 2022: The Board of Directors of Bawat Water Technologies AB (“Bawat” or the “Company”) intends to list the Company’s shares on the Nasdaq First North Premier Growth Market in Stockholm and carry out a new

STILRIDE raises £2.5m to produce sustainable e-motorcycles using ‘industrial origami’ robotics technology

Swedish technology and design startup STILRIDE  has raised £2.5m to produce sustainable electric motorcycles and scooters using a groundbreaking process dubbed ‘industrial origami’. The trailblazing manufacturing technique involves robots which are able to fold single sheets of recyclable steel into intricate, lightweight and durable new structures - significantly reducing the environmental impact of production. This process is being used to create the chassis and body for a fleet of next-generation e-motorcycles which will be made available to consumers in Europe

A-ROSA announces further details of A-ROSA SENA’s sustainability credentials

The first river cruise ship in Europe to generate electricity from exhaust heatRostock, 19 January 2022 – A-ROSA River Cruises has announced further details of the sustainability credentials of its new E-Motion ship A-ROSA SENA, which launches on the northern Rhine in May 2022. The range of technology features on board, which have been developed in partnership with the Concordia Damen shipyard, includes the ability to manage energy consumption in a highly efficient way and keep emissions to a minimum, making her the most climate-friendly river cruise ship on Europe’s rivers. She will be the

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 16 - 19 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Invitation to webcast in conjunction with Indutrade’s Year-End Report 2021

Indutrade will publish the Year-End Report 2021 on Wednesday 2 February, at around 7.30 am CET. A webcast will be held on the same day at 9.30 am CET. President and CEO Bo Annvik and CFO Patrik Johnson will present the report, followed by a Q&A session. The presentation will be in English and webcasted live through www.indutrade.com or: https://tv.streamfabriken.com/indutrade-q4-2021For phone access and to ask questions, please call: SE: +46 8 566 427 06UK: +44 3333 00 90 32US: +1 6 467 224 956 The presentation material will be published on our website after the meeting,

SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform

The breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care settings. Today SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced a partnership with the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), a German academic research institute of the Ruhr University Bochum, to develop a novel bladder cancer diagnostic platform. The diagnostic multiplexed lateral-flow technology aims

DanCann Pharma A/S: Highly promising analysis results

COPENHAGEN, Denmark, 19 January 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the ambitions to enter the European market with inhouse-produced biomaterial during 2022 has been further supported by the in-house analysis results that the Company has obtained after testing the selected cannabis genetics.DanCann Pharma has now reduced the number of varieties from 95 to nine. The Tetrahydrocannabinol (THC) content of these genetics are in all cases above the general minimum requirements from the market –

Storskogen is contemplating an issue of subsequent bonds under existing framework

Stockholm, January 19, 2022 – Storskogen Group AB (publ) (“Storskogen”) is contemplating an issue of subsequent senior unsecured bonds under an existing framework.Storskogen has mandated DNB Markets, Nordea, SEB and Swedbank as Joint Bookrunners to arrange a series of investor meetings on January 20, 2022, to explore the possibility to issue subsequent bonds of up to SEK 1 billion under the framework of Storskogen’s existing senior unsecured bond loan 2021/2025 (ISIN: SE0017084650) with a total framework of SEK 5 billion, under which an amount of SEK 2 billion is outstanding. The bond issue

AFRY and Tyréns awarded detailed design assignments for the East Link

The assignment assigned to AFRY and Tyréns includes the tender documents for the Gerstaberg – Långsjön railway line in Södertälje. Detailed designing is expected to begin in March 2022 and the entire assignment is expected to be completed in November 2023. The route is part of the East Link Project, a new double-track railway between Stockholm – Linköping, and the first part of Sweden's new main railways for high-speed railways.The Route Gerstaberg – Långsjön in Södertälje is part of the East Link, which at full expansion will be able to be operated by passenger trains with speeds up to 250

Letter from the CEO

As we start 2022, I thought it a good opportunity to review some of the important events of 2021 and discuss our most recent progress.The pandemic has during 2021 continued to play a role but even with the effects of Covid, it has still been a year including many milestones for SciBase. SciBase Strategy, MDR and NMSC SciBase’s strategy is based on gaining traction for our melanoma detection test in key markets and leveraging our core technology Electrical Impedance Spectroscopy (EIS) in additional clinical applications. Each new application uses the same core EIS technology but

Carbiotix starts evaluation project with global laboratory testing company

Carbiotix (publ) ("Carbiotix" or "Company") today announces that the Company has started an evaluation project with a top 5 global laboratory testing company present in over 40 countries and with annual sales exceeding 3 billion Euros. The purpose of the evaluation project will be to assess how Carbiotix LinkGut gut health testing service can be rolled out globally with improvements to cost, reliability and flexibility, while exposing CarbiAXOS and the Company’s Smart Prebiotic concept to leading food & beverage, nutraceutical and pharmaceutical companies.Kristofer Cook, CEO of Carbiotix,

There are no items matching the current filter
There are no more items matching the current filter
Back to top